末期腎不全<br>Advances in End-Stage Renal Diseases 2003 : International Conference on Dialysis V, January 29-31, 2003, Miami, Florida. Reprint of 'Blood Purification' Vol.21, No.1 (Renal Research Institute Seminars) （2003. 143 p. w. 2 col. and 44 figs. 29 cm）

個数：

末期腎不全
Advances in End-Stage Renal Diseases 2003 : International Conference on Dialysis V, January 29-31, 2003, Miami, Florida. Reprint of 'Blood Purification' Vol.21, No.1 (Renal Research Institute Seminars) （2003. 143 p. w. 2 col. and 44 figs. 29 cm）

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6～9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    【重要ご説明事項】
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版
  • 商品コード 9783805575355

基本説明

Reprint of: 'Blood Purification 2003, Vol. 21, No. 1'.

Full Description

As the fourth volume in this series (published annually on the occasion of the International Conference on Dialysis organized by the Renal Research Institute, New York) this book remains faithful to the concept of its predecessors: It covers not only current technological and therapeutic issues in the field of end-stage renal diseases, but also clinical issues related to chronic kidney disease with which nephrologists and caregivers are faced. This latest volume contains, among many others, contributions on the ADEMEX study, peritoneal dialysis, vascular access, inflammation and oxidant stress. Aspects of blood purification not directly related to end-stage renal diseases are also treated, such as affinity hemodialysis for antiviral therapy. Covering a broad spectrum of topics, this publication is a most helpful educational tool for young physicians, but also serves as a valuable reference book for experienced clinicians, providing as it does information on the most recent advances in dialysis technology and epidemiology of renal diseases.

Contents

Blood purification in non-renal critical illness, Kellum, J.A., Bellomo, R., Mehta, R., Ronco, C.; recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions, Mortier, S., De Vriese, A.S., Lameire, N.; PD and the future - the role of PD in the overall management of ESRD, Mendelssohn, D.C.; inflammation and atherosclerosis in end-stage renal disease, Zoccali, C., Mallamaci, F., Tripepi, G.; the ADEMEX study and PD adequacy, Burkart, J.M.; ADEMEX and HEMO trials - where are we going?, Prichard, S.; current studies on oxidant stress in dialysis, Handelman, G.J.; a kinetic model of inorganic phosphorus mass balance in haemodialysis therapy, Gotch, F.A., Panlilio, F., Sergeyeva, O., Rosales, L., Folden, T., Kaysen, G., Levin, N.W.; affinity haemodialysis for antiviral therapy, Tullis, R.H., Duffin, R.P., Zech, M., Ambrus, J.L.; renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure, Humes, H.D., Weitzel, W.F., Bartlett, R.H., Swaniker, F.C., Paganini, E.P.; slow continuous intracorporeal plasmapheresis for acute fluid overload, Handley, H.H., Gorsuch, R., Levin, N.W., Ronco, C.; sorbents in acute renal failure and the systemic inflammatory response syndrome, Winchester, J.F., Kellum, J.A., Ronco, C., Brady, J.A., Quartararo, P.J., Salsberg, J.A., Levin, N.W.; random sample (DOPPS) versus census-based (registry) approaches to kidney disease research, Port, F.K., Wolfe, R.A., Held, P.J., Young, E.W.; integrated vascular access management, Beathard, G.A.; haemodialysis vascular access dysfunction - from pathophysiology to novel therapies, Roy-Chaudhury, P., Kelly, B.S., Zhang, J., Narayana, A., Desai, P., Melhem, M., Duncan, H., Heffelfinger, S.C.; improving vascular access outcomes - a systems approach to eliminating structural barriers, Sands, J.J., Perry, M.A.; assays for parathyroid hormone and their use in patients with end-stage renal disease, Goodman, W.G.; anaemia in chronic kidney disease and congestive heart failure, Silverberg, D.S., Wexler, D., Blum, B., Iaina, A.; methods and reproducibility of measurement of resistivity in the calf using regional bioimpedance analysis, Zhu, F., Sarkar, S., Kaitwatcharachai, C., Greenwood, R., Ronco, C., Levin, N.W.; chronic kidney disease and the transplant recipient, Gill, J.S., Pereira, B.J.G.